Understanding the biological principles that underlie the mechanisms by which infectious agents adapt to and undermine the defense mechanisms of a host organism is critical for the development of therapeutic agents to fight disease. The LaMontagne Center for Infectious Disease conducts basic and translational research into the molecular mechanisms of pathogenesis of bacterial, viral, parasitic, or fungal infections and strategies for their prophylaxis and therapy. The LaMontagne Center was established at The University of Texas at Austin in November 2013 as the Center for Infectious Disease (CID) and was renamed just over three years later for scientist and public health champion John Ring LaMontagne. The LaMontagne Center, while located within the College of Natural Sciences, is composed of highly interdisciplinary researchers spanning at least four colleges: Natural Sciences, Engineering, Pharmacy, and the Dell Medical School.
The long-term goals of the LaMontagne Center are to promote interdisciplinary infectious disease research throughout the university; establish mentoring programs for undergraduates, graduate students, health professionals, and junior faculty; build ties to local and national medical centers; facilitate the submission of program project and training grants; and translate the results of research into clinical and public health practice.
The LaMontagne Center for Infectious Disease is the first interdisciplinary research center on a Tier One research university campus that aims to bridge the gap between basic and translational research into microbial and viral pathogenesis.
The LaMontagne Center consists of members from four distinct areas within the University: (1) The Cockrell School of Engineering, (2) The Dell Medical School, (3) The College of Natural Sciences, and (4) The School of Pharmacy.
Members bring expertise and research in over 30 different diseases including Ebola, HIV/AIDS, Breast Cancer, Leukemia, Arthritis, and Cystic Fibrosis. Faculty are currently investigating several aspects of infectious disease, including antibiotic resistance, vaccines, biotechnology, biofilms, and nanomedicine.
Our award-winning faculty includes one member of the National Academy of Sciences, one member of the National Academy of Medicine, six members of the American Academy of Microbiology, four members of the American Association of the Advancement of Science, and two Kavli Frontiers of Science Fellows.